XML 41 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2017
Accounting Policies [Abstract]  
Schedule of Finite-Lived Intangible Assets
The following table summarizes the carrying value of our intangible assets as of December 31, 2017 and 2016:
 
 
December 31,
In thousands
 
2017
 
2016
Intangible asset value
 
$
37,848

 
$
37,848

Accumulated amortization
 
(10,645
)
 
(8,215
)
Net book value
 
$
27,203

 
$
29,633

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
As of December 31, 2017, our estimated amortization expense for our intangible assets subject to amortization over the next five years is as follows:
In thousands
 
 
2018
 
$
2,430

2019
 
2,430

2020
 
2,430

2021
 
2,430

2022
 
2,430

 
Schedule of Earnings Per Share, Basic and Diluted Reconciliation
The following table sets forth the reconciliations of net income (loss) and weighted average shares used for purposes of calculating basic and diluted net income (loss) per common share for the periods indicated:
 
 
Year Ended December 31,
In thousands
 
2017
 
2016
 
2015
Numerator
 
 
 
 
 
 
Net income (loss) – basic
 
$
163,152

 
$
(976,177
)
 
$
(4,385,448
)
Effect of potentially dilutive securities
 
 
 
 
 
 
Interest on convertible senior notes
 
49

 

 

Net income (loss) – diluted
 
$
163,201

 
$
(976,177
)
 
$
(4,385,448
)
 
 
 
 
 
 
 
Denominator
 
 
 
 
 
 
Weighted average common shares outstanding – basic
 
390,928

 
373,859

 
348,802

Effect of potentially dilutive securities
 
 
 
 

 
 

Restricted stock, stock options, SARs and performance-based equity awards
 
2,242

 

 

Convertible senior notes
 
2,751

 

 

Weighted average common shares outstanding – diluted
 
395,921

 
373,859

 
348,802

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following securities could potentially dilute earnings per share in the future, but were excluded from the computation of diluted net income (loss) per share, as their effect would have been antidilutive:
 
 
Year Ended December 31,
In thousands
 
2017
 
2016
 
2015
Stock options and SARs
 
4,512

 
6,427

 
9,619

Restricted stock and performance-based equity awards
 
5,645

 
5,816

 
3,867